Berberine, the primary alkaloid found in barberry and several other medicinal plants, has long been studied for its antimicrobial properties. A clinical trial published in the Journal of Infectious Disease (May 1987;155(5):979–984) evaluated the effectiveness of berberine sulfate in treating bacterial diarrhea.
Study Overview
The study included 165 patients with acute diarrhea caused by either:
-
Escherichia coli, or
-
Vibrio cholerae
Participants were randomly assigned to one of two groups:
-
Treatment group: received a single 400 mg dose of berberine sulfate
-
Control group: received no berberine
Results for E. coli–Related Diarrhea
Patients whose diarrhea was caused by E. coli showed clear improvements:
-
The berberine group had a significant reduction in stool volume compared to controls
-
After 24 hours, 42% of patients receiving berberine had complete resolution of diarrhea, compared with 20% of the control group
Results for Cholera-Related Diarrhea
In patients infected with Vibrio cholerae:
-
Berberine reduced total stool volume
-
However, when 1200 mg of berberine was combined with tetracycline, there was no significant improvement compared with tetracycline alone
This suggests that while berberine may help reduce stool output in cholera, it does not appear to enhance the effects of standard antibiotic treatment.
Educational only — not medical advice.
